{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T09:03:55Z","timestamp":1774343035953,"version":"3.50.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,8]]},"DOI":"10.7759\/cureus.68936","type":"journal-article","created":{"date-parts":[[2024,9,8]],"date-time":"2024-09-08T13:43:58Z","timestamp":1725803038000},"source":"Crossref","is-referenced-by-count":1,"title":["Erythroderma Following Pfizer-BioNTech COVID-19 Vaccination in a Patient With Atopic Dermatitis: A Case Report"],"prefix":"10.7759","author":[{"given":"Marina","family":"Handal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kawaiola Cael","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Bartos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/v15071423","article-title":"The impact of COVID-19 vaccination on inflammatory skin disorders and other cutaneous diseases: a review of the published literature","volume":"15","author":"Martora F","year":"2023","unstructured":"Martora F, Battista T, Ruggiero A, Scalvenzi M, Villani A, Megna M, Potestio L. The impact of COVID-19 vaccination on inflammatory skin disorders and other cutaneous diseases: a review of the published literature. Viruses. 2023, 15:1423. 10.3390\/v15071423","journal-title":"Viruses"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.03.092","article-title":"Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: a registry-based study of 414 cases","volume":"85","author":"McMahon DE","year":"2021","unstructured":"McMahon DE, Amerson E, Rosenbach M, et al.. Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: a registry-based study of 414 cases. J Am Acad Dermatol. 2021, 85:46-55. 10.1016\/j.jaad.2021.03.092","journal-title":"J Am Acad Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ad.2018.05.011","article-title":"A practical approach to the diagnosis and treatment of adult erythroderma","volume":"109","author":"Cuellar-Barboza A","year":"2018","unstructured":"Cuellar-Barboza A, Ocampo-Candiani J, Herz-Ruelas ME. A practical approach to the diagnosis and treatment of adult erythroderma. Actas Dermosifiliogr (Engl Ed). 2018, 109:777-90. 10.1016\/j.ad.2018.05.011","journal-title":"Actas Dermosifiliogr (Engl Ed)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-75623-3_19","article-title":"Erythroderma","author":"Harper-Kirksey K","year":"2018","unstructured":"Harper-Kirksey K. Erythroderma. Life-Threatening Rashes. Rose E (ed): Springer, Cham, Switzerland; 2018. 265-77. 10.1007\/978-3-319-75623-3_19"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13030645","article-title":"Erythroderma: a retrospective study of 212 patients hospitalized in a tertiary center in Lower Silesia, Poland","volume":"13","author":"Kliniec K","year":"2024","unstructured":"Kliniec K, Snopkowska A, \u0141yko M, Jankowska-Konsur A. Erythroderma: a retrospective study of 212 patients hospitalized in a tertiary center in Lower Silesia, Poland. J Clin Med. 2024, 13:645. 10.3390\/jcm13030645","journal-title":"J Clin Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-66040-7","article-title":"Erythroderma: a prospective study of 309 patients followed for 12 years in a tertiary center","volume":"10","author":"Miyashiro D","year":"2020","unstructured":"Miyashiro D, Sanches JA. Erythroderma: a prospective study of 309 patients followed for 12 years in a tertiary center. Sci Rep. 2020, 10:9774. 10.1038\/s41598-020-66040-7","journal-title":"Sci Rep"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15363","article-title":"Erythroderma related with the first dose of Pfizer-BioNTech BNT16B2b2 COVID-19 mRNA vaccine in a patient with psoriasis","volume":"35","author":"Durmus O","year":"2022","unstructured":"Durmus O, Akdogan N, Karadag O, Gokoz O. Erythroderma related with the first dose of Pfizer-BioNTech BNT16B2b2 COVID-19 mRNA vaccine in a patient with psoriasis. Dermatol Ther. 2022, 35:e15363. 10.1111\/dth.15363","journal-title":"Dermatol Ther"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2022.07.041","article-title":"Erythrodermic psoriasis after COVID-19 vaccination","volume":"28","author":"Trepanowski N","year":"2022","unstructured":"Trepanowski N, Coleman EL, Melson G, Brem CE, Lam CS. Erythrodermic psoriasis after COVID-19 vaccination. JAAD Case Rep. 2022, 28:123-6. 10.1016\/j.jdcr.2022.07.041","journal-title":"JAAD Case Rep"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2022.06.689","article-title":"31047 erythrodermic psoriasis secondary to the COVID-19 Moderna vaccine","volume":"87","author":"Pab\u00f3n-Cartagena G","year":"2022","unstructured":"Pab\u00f3n-Cartagena G, Pelet del Toro NM, Russo M. 31047 erythrodermic psoriasis secondary to the COVID-19 Moderna vaccine. J Am Acad Dermatol. 2022, 87:AB164. 10.1016\/j.jaad.2022.06.689","journal-title":"J Am Acad Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.12788\/cutis.1010","article-title":"Erythrodermic pityriasis rubra pilaris following COVID-19 vaccination","volume":"113","author":"Abdelkader HA","year":"2024","unstructured":"Abdelkader HA, Khedr H, El-Komy MH. Erythrodermic pityriasis rubra pilaris following COVID-19 vaccination. Cutis. 2024, 113:E22-4. 10.12788\/cutis.1010","journal-title":"Cutis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2023.09.024","article-title":"Erythrodermic pityriasis rubra pilaris following SARS-CoV-2 vaccination treated with bimekizumab","volume":"42","author":"Saad M","year":"2023","unstructured":"Saad M, Bose R. Erythrodermic pityriasis rubra pilaris following SARS-CoV-2 vaccination treated with bimekizumab. JAAD Case Rep. 2023, 42:7-11. 10.1016\/j.jdcr.2023.09.024","journal-title":"JAAD Case Rep"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2022.03.013","article-title":"Pityriasis rubra pilaris potentially triggered by messenger RNA-1273 COVID vaccine","volume":"23","author":"Ajebo EM","year":"2022","unstructured":"Ajebo EM, Howard JD, Anand D, Davis LS. Pityriasis rubra pilaris potentially triggered by messenger RNA-1273 COVID vaccine. JAAD Case Rep. 2022, 23:114-6. 10.1016\/j.jdcr.2022.03.013","journal-title":"JAAD Case Rep"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/ced.14970","article-title":"Abrupt onset of Sweet syndrome, pityriasis rubra pilaris, pityriasis lichenoides et varioliformis acuta and erythema multiforme: unravelling a possible common trigger, the COVID-19 vaccine","volume":"47","author":"Sechi A","year":"2022","unstructured":"Sechi A, Pierobon E, Pezzolo E, et al.. Abrupt onset of Sweet syndrome, pityriasis rubra pilaris, pityriasis lichenoides et varioliformis acuta and erythema multiforme: unravelling a possible common trigger, the COVID-19 vaccine. Clin Exp Dermatol. 2022, 47:437-40. 10.1111\/ced.14970","journal-title":"Clin Exp Dermatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.19046","article-title":"Clinical characteristics of patients with pityriasis rubra pilaris following SARS-CoV-2 vaccination","author":"Gambichler T","year":"2023","unstructured":"Gambichler T. Clinical characteristics of patients with pityriasis rubra pilaris following SARS-CoV-2 vaccination. J Eur Acad Dermatol Venereol. 2023, 10.1111\/jdv.19046","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/280177-erythroderma-following-pfizer-biontech-covid-19-vaccination-in-a-patient-with-atopic-dermatitis-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,8]],"date-time":"2024-09-08T13:44:03Z","timestamp":1725803043000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/280177-erythroderma-following-pfizer-biontech-covid-19-vaccination-in-a-patient-with-atopic-dermatitis-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,8]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.68936","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,8]]}}}